Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116764) titled 'A Study to test topical Gentamicin for Treating Epidermolysis Bullosa Caused by nonsense mutations' on Sept. 1.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Other Blinding and masking:Open Label
Primary Sponsor: Sri Madhusudan Sai Institute of Medical Sciences and Research
Condition:
Health Condition 1: Q811- Epidermolysis bullosa letalis
Health Condition 2: Q812- Epidermolysis bullosa dystrophica
Health Condition 3: Q818- Other epidermolysis b...